A Dark Vector Cognition product

Item 1. FINANCIAL STATEMENTS

169K characters. Original on sec.gov ·

Item 1. FINANCIAL STATEMENTS

The 56 tables in Item 1. FINANCIAL STATEMENTS as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

Dow Inc. and Subsidiaries

Consolidated Statements of Income

Three Months EndedNine Months Ended
In millions, except per share amounts (Unaudited)Sep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Net sales$9,973$10,879$30,508$32,559
Cost of sales9,2429,80928,52328,888
Research and development expenses191208579608
Selling, general and administrative expenses3403961,0531,228
Amortization of intangibles4676185234
Restructuring and asset related charges - net232482269
Equity in earnings (losses) of nonconsolidated affiliates(72)2(122)45
Sundry income (expense) - net185119345256
Interest income4736114143
Interest expense and amortization of debt discount221199646595
Income (loss) before income taxes70324(963)1,381
Provision (credit) for income taxes(54)844145
Net income (loss)124240(967)1,236
Net income attributable to noncontrolling interests622611367
Net income (loss) available for Dow Inc. common stockholders$62$214$(1,080)$1,169
Per common share data:
Earnings (loss) per common share - basic$0.08$0.30$(1.53)$1.65
Earnings (loss) per common share - diluted$0.08$0.30$(1.53)$1.65
Weighted-average common shares outstanding - basic711.8702.3709.4703.5
Weighted-average common shares outstanding - diluted713.2703.6709.4704.9
Depreciation$536$501$1,586$1,470
Capital expenditures$564$736$1,911$2,173

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income

Three Months EndedNine Months Ended
In millions (Unaudited)Sep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Net income (loss)$124$240$(967)$1,236
Other comprehensive income (loss), net of tax
Unrealized gains on investments57346789
Cumulative translation adjustments(33)19921834
Pension and other postretirement benefit plans28186952
Derivative instruments1131(7)3
Total other comprehensive income63282347178
Comprehensive income (loss)187522(620)1,414
Comprehensive income attributable to noncontrolling interests, net of tax622611367
Comprehensive income (loss) attributable to Dow Inc.$125$496$(733)$1,347

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries

Consolidated Balance Sheets

In millions, except share amounts (Unaudited)Sep 30, 2025Dec 31, 2024
Assets
Current Assets
Cash and cash equivalents$4,609$2,189
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2025: $71; 2024: $95)5,0444,756
Other2,1172,108
Inventories6,6756,544
Other current assets1,201993
Total current assets (variable interest entities restricted - 2025: $219; 2024: $55)19,64616,590
Investments
Investment in nonconsolidated affiliates1,2551,266
Other investments (investments carried at fair value - 2025: $2,073; 2024: $2,047)2,8123,033
Noncurrent receivables427380
Total investments4,4944,679
Property
Property65,32762,121
Less: Accumulated depreciation42,78840,117
Net property (variable interest entities restricted - 2025: $2,357; 2024: $122)22,53922,004
Other Assets
Goodwill8,6908,565
Other intangible assets (net of accumulated amortization - 2025: $5,702; 2024: $5,394)1,5461,721
Operating lease right-of-use assets1,3141,268
Deferred income tax assets1,4181,257
Deferred charges and other assets1,3431,228
Total other assets (variable interest entities restricted - 2025: $232; 2024: $15)14,31114,039
Total Assets$60,990$57,312
Liabilities and Equity
Current Liabilities
Notes payable$133$135
Long-term debt due within one year413497
Accounts payable:
Trade4,5354,847
Other1,6731,694
Operating lease liabilities - current324318
Income taxes payable271276
Accrued and other current liabilities2,7552,521
Total current liabilities (variable interest entities nonrecourse - 2025: $413; 2024: $24)10,10410,288
Long-Term Debt (variable interest entities nonrecourse - 2025: $172; 2024: $—)17,70915,711
Other Noncurrent Liabilities
Deferred income tax liabilities383392
Pension and other postretirement benefits - noncurrent4,6564,736
Asbestos-related liabilities - noncurrent645713
Operating lease liabilities - noncurrent1,046984
Other noncurrent obligations7,3836,637
Total other noncurrent liabilities (variable interest entities nonrecourse - 2025: $353; 2024: $13)14,11313,462
Stockholders’ Equity
Common stock (authorized 5,000,000,000 shares of $0.01 par value each; issued 2025: 785,965,252 shares; 2024: 784,471,939 shares)88
Additional paid-in capital11,0999,203
Retained earnings18,57620,909
Accumulated other comprehensive loss(7,763)(8,110)
Treasury stock at cost (2025: 75,197,860 shares; 2024: 80,859,145 shares)(4,379)(4,655)
Dow Inc.’s stockholders’ equity17,54117,355
Noncontrolling interests1,523496
Total equity19,06417,851
Total Liabilities and Equity$60,990$57,312

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries

Consolidated Statements of Cash Flows

In millions (Unaudited)Nine Months Ended
Sep 30, 2025Sep 30, 2024
Operating Activities
Net income (loss)$(967)$1,236
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization2,1262,143
Credit for deferred income tax(179)(134)
Earnings of nonconsolidated affiliates less than dividends received312221
Net periodic pension benefit credit(73)(143)
Pension contributions(145)(92)
Net gain on sales of assets, businesses and investments(211)(58)
Restructuring and asset related charges - net82269
Other net loss134332
Changes in assets and liabilities, net of effects of acquired and divested companies:
Accounts and notes receivable(400)(818)
Inventories(132)(676)
Accounts payable(492)601
Other assets and liabilities, net(31)(589)
Cash provided by operating activities - continuing operations7642,092
Cash provided by (used for) operating activities - discontinued operations(16)8
Cash provided by operating activities7482,100
Investing Activities
Capital expenditures(1,911)(2,173)
Proceeds from incentives related to capital expenditures132—
Investment in gas field developments(110)(157)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested13536
Acquisitions of property and businesses, net of cash acquired—(121)
Investments in and loans to nonconsolidated affiliates(21)(25)
Proceeds from sales of ownership interests in nonconsolidated affiliates125—
Purchases of investments(523)(1,381)
Proceeds from sales and maturities of investments7112,386
Other investing activities, net5(21)
Cash used for investing activities(1,457)(1,456)
Financing Activities
Changes in short-term notes payable36(61)
Proceeds from issuance of short-term debt greater than three months50114
Payments on short-term debt greater than three months(46)(6)
Proceeds from issuance of long-term debt2,6521,443
Payments on long-term debt(1,207)(224)
Collections on securitization programs, net of remittances(3)28
Purchases of treasury stock—(494)
Proceeds from issuance of stock—51
Transaction financing, debt issuance and other costs(130)(13)
Employee taxes paid for share-based payment arrangements(16)(38)
Distributions to noncontrolling interests(93)(49)
Proceeds from sale of noncontrolling interests2,943—
Dividends paid to stockholders(1,239)(1,474)
Other financing activities, net(6)—
Cash provided by (used for) financing activities2,941(723)
Effect of exchange rate changes on cash, cash equivalents and restricted cash25918
Summary
Increase (decrease) in cash, cash equivalents and restricted cash2,491(61)
Cash, cash equivalents and restricted cash at beginning of period2,2633,048
Cash, cash equivalents and restricted cash at end of period$4,754$2,987
Less: Restricted cash and cash equivalents, included in "Other current assets"145104
Cash and cash equivalents at end of period$4,609$2,883

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries

Consolidated Statements of Equity

Three Months EndedNine Months Ended
In millions, except per share amounts (Unaudited)Sep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Common Stock
Balance at beginning and end of period$8$8$8$8
Additional Paid-in Capital
Balance at beginning of period10,7589,0129,2038,880
Common stock issued/sold———51
Stock-based compensation9786293285
Treasury stock issuances - compensation and benefit plans(96)(43)(276)(161)
Sale of membership interest in Diamond Infrastructure Solutions (Note 17)339—1,879—
Other1———
Balance at end of period11,0999,05511,0999,055
Retained Earnings
Balance at beginning of period18,76621,73920,90921,774
Net income (loss) available for Dow Inc. common stockholders62214(1,080)1,169
Dividends to stockholders(249)(490)(1,239)(1,474)
Common control transaction———10
Other(3)(4)(14)(20)
Balance at end of period18,57621,45918,57621,459
Accumulated Other Comprehensive Loss
Balance at beginning of period(7,826)(7,785)(8,110)(7,681)
Other comprehensive income63282347178
Balance at end of period(7,763)(7,503)(7,763)(7,503)
Treasury Stock
Balance at beginning of period(4,475)(4,656)(4,655)(4,374)
Treasury stock purchases—(95)—(495)
Treasury stock issuances - compensation and benefit plans9643276161
Balance at end of period(4,379)(4,708)(4,379)(4,708)
Dow Inc.'s stockholders' equity17,54118,31117,54118,311
Noncontrolling Interests1,5235301,523530
Total Equity$19,064$18,841$19,064$18,841
Dividends declared per share of common stock$0.35$0.70$1.75$2.10

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Income

Three Months EndedNine Months Ended
In millions (Unaudited)Sep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Net sales$9,973$10,879$30,508$32,559
Cost of sales9,2419,80028,52028,877
Research and development expenses191208579608
Selling, general and administrative expenses3403961,0531,228
Amortization of intangibles4676185234
Restructuring and asset related charges - net232482269
Equity in earnings (losses) of nonconsolidated affiliates(72)2(122)45
Sundry income (expense) - net184118360253
Interest income4738117152
Interest expense and amortization of debt discount221199646595
Income (loss) before income taxes70334(942)1,398
Provision (credit) for income taxes(54)844145
Net income (loss)124250(946)1,253
Net income attributable to noncontrolling interests622611367
Net income (loss) available for The Dow Chemical Company common stockholder$62$224$(1,059)$1,186
Depreciation$536$501$1,586$1,470
Capital expenditures$564$736$1,911$2,173

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Comprehensive Income

Three Months EndedNine Months Ended
In millions (Unaudited)Sep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Net income (loss)$124$250$(946)$1,253
Other comprehensive income (loss), net of tax
Unrealized gains on investments57346789
Cumulative translation adjustments(33)19921834
Pension and other postretirement benefit plans28186952
Derivative instruments1131(7)3
Total other comprehensive income63282347178
Comprehensive income (loss)187532(599)1,431
Comprehensive income attributable to noncontrolling interests, net of tax622611367
Comprehensive income (loss) attributable to The Dow Chemical Company$125$506$(712)$1,364

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Balance Sheets

In millions, except share amounts (Unaudited)Sep 30, 2025Dec 31, 2024
Assets
Current Assets
Cash and cash equivalents$4,609$2,189
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2025: $71; 2024: $95)5,0444,756
Other2,1202,116
Inventories6,6756,544
Other current assets1,162960
Total current assets (variable interest entities restricted - 2025: $219; 2024: $55)19,61016,565
Investments
Investment in nonconsolidated affiliates1,2551,266
Other investments (investments carried at fair value - 2025: $2,073; 2024: $2,047)2,8123,033
Noncurrent receivables421374
Total investments4,4884,673
Property
Property65,32762,121
Less accumulated depreciation42,78840,117
Net property (variable interest entities restricted - 2025: $2,357; 2024: $122)22,53922,004
Other Assets
Goodwill8,6908,565
Other intangible assets (net of accumulated amortization - 2025: $5,702; 2024: $5,394)1,5461,721
Operating lease right-of-use assets1,3141,268
Deferred income tax assets1,4181,257
Deferred charges and other assets1,3431,228
Total other assets (variable interest entities restricted - 2025: $232; 2024: $15)14,31114,039
Total Assets$60,948$57,281
Liabilities and Equity
Current Liabilities
Notes payable$133$135
Long-term debt due within one year413497
Accounts payable:
Trade4,5354,847
Other1,6731,732
Operating lease liabilities - current324318
Income taxes payable271276
Accrued and other current liabilities2,6372,405
Total current liabilities (variable interest entities nonrecourse - 2025: $413; 2024: $24)9,98610,210
Long-Term Debt (variable interest entities nonrecourse - 2025: $172; 2024: $—)17,70915,711
Other Noncurrent Liabilities
Deferred income tax liabilities383392
Pension and other postretirement benefits - noncurrent4,6564,736
Asbestos-related liabilities - noncurrent645713
Operating lease liabilities - noncurrent1,046984
Other noncurrent obligations7,2436,503
Total other noncurrent liabilities (variable interest entities nonrecourse - 2025: $353: 2024: $13)13,97313,328
Stockholder's Equity
Common stock (authorized and issued 100 shares of $0.01 par value each)——
Additional paid-in capital11,7989,626
Retained earnings13,72216,020
Accumulated other comprehensive loss(7,763)(8,110)
The Dow Chemical Company’s stockholder's equity17,75717,536
Noncontrolling interests1,523496
Total equity19,28018,032
Total Liabilities and Equity$60,948$57,281

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Cash Flows

In millions (Unaudited)Nine Months Ended
Sep 30, 2025Sep 30, 2024
Operating Activities
Net income (loss)$(946)$1,253
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization2,1262,143
Credit for deferred income tax(179)(134)
Earnings of nonconsolidated affiliates less than dividends received312221
Net periodic pension benefit credit(73)(143)
Pension contributions(145)(92)
Net gain on sales of assets, businesses and investments(211)(58)
Restructuring and asset related charges - net82269
Other net loss136333
Changes in assets and liabilities, net of effects of acquired and divested companies:
Accounts and notes receivable(400)(818)
Inventories(132)(676)
Accounts payable(492)601
Other assets and liabilities, net(72)(583)
Cash provided by operating activities7462,116
Investing Activities
Capital expenditures(1,911)(2,173)
Proceeds from incentives related to capital expenditures132—
Investment in gas field developments(110)(157)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested13536
Acquisitions of property and businesses, net of cash acquired—(121)
Investments in and loans to nonconsolidated affiliates(21)(25)
Proceeds from sales of ownership interests in nonconsolidated affiliates125—
Purchases of investments(523)(1,381)
Proceeds from sales and maturities of investments7112,386
Other investing activities, net5(21)
Cash used for investing activities(1,457)(1,456)
Financing Activities
Changes in short-term notes payable36(61)
Proceeds from issuance of short-term debt greater than three months50114
Payments on short-term debt greater than three months(46)(6)
Proceeds from issuance of long-term debt2,6521,443
Payments on long-term debt(1,207)(224)
Collections on securitization programs, net of remittances(3)28
Proceeds from issuance of stock—51
Transaction financing, debt issuance and other costs(130)(13)
Employee taxes paid for share-based payment arrangements(16)(38)
Distributions to noncontrolling interests(93)(49)
Proceeds from sale of noncontrolling interests2,943—
Dividends paid to Dow Inc.(1,237)(1,984)
Other financing activities, net(6)—
Cash provided by (used for) financing activities2,943(739)
Effect of exchange rate changes on cash, cash equivalents and restricted cash25918
Summary
Increase (decrease) in cash, cash equivalents and restricted cash2,491(61)
Cash, cash equivalents and restricted cash at beginning of period2,2633,048
Cash, cash equivalents and restricted cash at end of period$4,754$2,987
Less: Restricted cash and cash equivalents, included in "Other current assets"145104
Cash and cash equivalents at end of period$4,609$2,883

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Equity

Three Months EndedNine Months Ended
In millions (Unaudited)Sep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Common Stock
Balance at beginning and end of period$—$—$—$—
Additional Paid-in Capital
Balance at beginning of period11,3629,3419,6269,091
Issuance of parent company stock - Dow Inc.———51
Stock-based compensation9786293285
Sale of membership interest in Diamond Infrastructure Solutions (Note 17)339—1,879—
Balance at end of period11,7989,42711,7989,427
Retained Earnings
Balance at beginning of period13,90216,96416,02017,495
Net income (loss) available for The Dow Chemical Company common stockholder62224(1,059)1,186
Dividends to Dow Inc.(240)(600)(1,225)(2,077)
Other(2)(3)(14)(19)
Balance at end of period13,72216,58513,72216,585
Accumulated Other Comprehensive Loss
Balance at beginning of period(7,826)(7,785)(8,110)(7,681)
Other comprehensive income63282347178
Balance at end of period(7,763)(7,503)(7,763)(7,503)
The Dow Chemical Company's stockholder's equity17,75718,50917,75718,509
Noncontrolling Interests1,5235301,523530
Total Equity$19,280$19,039$19,280$19,039

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries (Unaudited)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

Table of Contents

NotePage
1Consolidated Financial Statements15
2Recent Accounting Guidance16
3Revenue17
4Divestitures19
5Restructuring and Asset Related Charges - Net19
6Supplementary Information22
7Income Taxes23
8Earnings Per Share Calculations23
9Inventories24
10Nonconsolidated Affiliates24
11Goodwill25
12Transfers of Financial Assets25
13Notes Payable, Long Term Debt and Available Credit Facilities26
14Commitments and Contingencies28
15Leases31
16Accumulated Other Comprehensive Loss32
17Noncontrolling Interests33
18Pension and Other Postretirement Benefit Plans34
19Stock-Based Compensation34
20Financial Instruments35
21Fair Value Measurements39
22Variable Interest Entities40
23Segments and Geographic Regions41

NOTE 1 – CONSOLIDATED FINANCIAL STATEMENTS

Basis of Presentation

Dow Inc. is the direct parent company of The Dow Chemical Company and its consolidated subsidiaries ("TDCC" and together with Dow Inc., "Dow" or the "Company"). The unaudited interim consolidated financial statements of Dow Inc. and TDCC were prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and reflect all adjustments (including normal recurring accruals) which, in the opinion of management, are considered necessary for the fair presentation of the results for the periods presented. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2024 ("2024 10-K").

As a result of the parent/subsidiary relationship between Dow Inc. and TDCC, and considering that the financial statements and disclosures of each company are substantially similar, the companies are filing a combined report for this Quarterly Report on Form 10-Q. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Transactions between TDCC and Dow Inc. are treated as related party transactions for TDCC.

Table of Contents

Except as otherwise indicated by the context, the term "Union Carbide" means Union Carbide Corporation, a wholly owned subsidiary of the Company. Additionally, the term "Diamond Infrastructure Solutions" means Dow InfraCo, LLC, an entity that owns and operates infrastructure assets at certain Dow locations on the U.S. Gulf Coast and became a consolidated variable interest entity on May 1, 2025. See Notes 17 and 22 for additional information about Diamond Infrastructure Solutions.

NOTE 2 – RECENT ACCOUNTING GUIDANCE

Recently Adopted Accounting Guidance

In the fourth quarter of 2024, the Company adopted the annual and interim disclosure requirements of Accounting Standards Update ("ASU") 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures." The amendments expand a public business entity's segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM"), clarifying when an entity may report one or more additional measures to assess segment performance, requiring enhanced interim disclosures, providing new disclosure requirements for entities with a single reportable segment, and requiring other new disclosures. See Note 23 for applicable reportable segment disclosures required by this guidance.

Accounting Guidance Issued But Not Adopted at September 30, 2025

In December 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures," which is intended to enhance the transparency, decision usefulness and effectiveness of income tax disclosures. The amendments in this ASU require a public business entity to disclose a tabular tax rate reconciliation, using both percentages and currency, with specific categories. A public business entity is also required to provide a qualitative description of the states and local jurisdictions that make up the majority of the effect of the state and local income tax category and the net amount of income taxes paid, disaggregated by federal, state and foreign taxes and also disaggregated by individual jurisdictions. The amendments also remove certain disclosures that are no longer considered cost beneficial. The amendments are effective prospectively for annual periods beginning after December 15, 2024, and early adoption and retrospective application are permitted. While the adoption of ASU 2023-09 will result in enhanced disclosures, the Company does not expect it will have a material impact on its financial condition or results of operations.

In November 2024, the FASB issued ASU 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses," which is intended to improve disclosures about a public business entity's expenses and address requests from investors for more detailed information about the types of expenses in commonly presented expense captions. Such information should allow investors to better understand an entity's performance, assess future cash flows, and compare performance over time and with other entities. The amendments will require public business entities to disclose in the notes to the financial statements, at each interim and annual reporting period, specific information about certain costs and expenses, including purchases of inventory, employee compensation, depreciation, and intangible asset amortization included in each expense caption presented on the face of the income statement, and the total amount of an entity's selling expenses. The amendments are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, and may be applied either prospectively or retrospectively. Early adoption is permitted. While the adoption of ASU 2024-03 will result in enhanced disclosures, the Company does not expect it will have a material impact on its financial condition or results of operations.

In September 2025, the FASB issued ASU 2025-06, "Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software," which is intended to modernize the accounting for the costs of internal-use software given the evolution of software development to the incremental and iterative development method. The amendments remove all references to prescriptive and sequential development stages and, instead, require an entity to start capitalizing software costs when management has authorized and committed to funding the software project, and it is probable that the project will be completed and the software will be used to perform the function intended. The amendments are effective for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period with the amendments to be applied using a prospective, modified or retrospective transition approach. The Company is currently evaluating the impact of adopting this guidance on the consolidated financial statements.

Table of Contents

SEC Final Rules Not Adopted at September 30, 2025

In March 2024, the U.S. Securities and Exchange Commission ("SEC") adopted final rules under SEC Release Nos. 33-11275 and 34-99678, "The Enhancement and Standardization of Climate-Related Disclosures for Investors," which requires registrants to disclose certain climate-related information in registration statements and annual reports. As a large accelerated filer, most disclosure requirements would be effective for the Company beginning in the year ending December 31, 2025, with certain greenhouse gas emissions disclosures required for the year ending December 31, 2026. In April 2024, the SEC issued an order to stay the final rules until various legal challenges are resolved by the U.S. Court of Appeals for the Eighth Circuit ("Court of Appeals"). In March 2025, the SEC voted to end its defense of the final rules and, in July 2025, the SEC asked the Court of Appeals to resolve the merits of the challenge to the final rules. In September 2025, the Court of Appeals ordered the litigation to be held in abeyance pending further action from the SEC.

NOTE 3 – REVENUE

Revenue Recognition

The majority of the Company's revenue is derived from product sales. The Company's revenue related to product sales was 98 percent for the three and nine months ended September 30, 2025 (97 percent and 98 percent for the three and nine months ended September 30, 2024, respectively). The remaining sales were primarily related to the Company's insurance operations and licensing of patents and technologies. Product sales consist of sales of the Company's products to manufacturers and distributors. The Company considers order confirmations or purchase orders, which in some cases are governed by master supply agreements, to be contracts with a customer. The Company enters into licensing arrangements in which it licenses certain rights of its patents and technology to customers. Revenue from the Company’s licenses for patents and technology is derived from sales-based royalties and licensing arrangements based on billing schedules established in each contract.

Remaining Performance Obligations

Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. At September 30, 2025, the Company had unfulfilled performance obligations of $735 million ($759 million at December 31, 2024) related to the licensing of technology. The Company expects revenue to be recognized for the remaining performance obligations over the next five years.

The Company has additional remaining performance obligations for product sales that have expected durations of one year or less, product sales of materials delivered through a pipeline for which the Company has elected the "right to invoice" practical expedient, and variable consideration attributable to royalties for licenses of patents and technology. The Company has received advance payments from customers related to long-term supply agreements that are deferred and recognized over the life of the contract, with remaining contract terms that range up to 18 years. The Company will have rights to future consideration for revenue recognized when product is delivered to the customer. These payments are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets.

Table of Contents

Disaggregation of Revenue

The Company disaggregates its revenue from contracts with customers by operating segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. See details in the tables below:

Net Trade Sales by Segment and BusinessThree Months EndedNine Months Ended
In millionsSep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Hydrocarbons & Energy$1,233$1,433$4,161$4,347
Packaging and Specialty Plastics3,6584,08311,06512,114
Packaging & Specialty Plastics$4,891$5,516$15,226$16,461
Industrial Solutions$1,004$1,039$3,043$3,107
Polyurethanes & Construction Chemicals1,8261,9195,4205,805
Other44129
Industrial Intermediates & Infrastructure$2,834$2,962$8,475$8,921
Coatings & Performance Monomers$809$891$2,518$2,704
Consumer Solutions1,2731,3233,7643,905
Performance Materials & Coatings$2,082$2,214$6,282$6,609
Corporate$166$187$525$568
Total$9,973$10,879$30,508$32,559
Net Trade Sales by Geographic RegionThree Months EndedNine Months Ended
In millionsSep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
U.S. & Canada$3,914$4,149$12,129$12,470
EMEAI 13,0903,5689,63610,624
Asia Pacific1,8381,8905,4335,712
Latin America1,1311,2723,3103,753
Total$9,973$10,879$30,508$32,559

1.Europe, Middle East, Africa and India.

Contract Assets and Liabilities

The Company receives payments from customers based upon contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the Company's contractual right to consideration for completed performance obligations not yet invoiced. Contract liabilities include payments received in advance of performance under the contract and are recognized in revenue when the performance obligations are met. "Contract liabilities - current" primarily reflects deferred revenue from prepayments from customers for product to be delivered in 12 months or less and royalty payments that are deferred and will be recognized in 12 months or less. "Contract liabilities - noncurrent" includes advance payments that the Company has received from customers related to long-term supply agreements and royalty payments that are deferred and recognized over the life of the contract.

Revenue recognized in the first nine months of 2025 from amounts included in contract liabilities at the beginning of the period was approximately $170 million (approximately $135 million in the first nine months of 2024). In the first nine months of 2025 and 2024, the amount of contract assets reclassified to receivables as a result of the right to the transaction consideration becoming unconditional was insignificant.

Table of Contents

The following table summarizes contract assets and liabilities at September 30, 2025 and December 31, 2024:

Contract Assets and LiabilitiesBalance Sheet ClassificationSep 30, 2025Dec 31, 2024
In millions
Accounts and notes receivable - tradeAccounts and notes receivable - trade$5,044$4,756
Contract assets - noncurrentDeferred charges and other assets$—$2
Contract liabilities - currentAccrued and other current liabilities$220$244
Contract liabilities - noncurrent 1Other noncurrent obligations$1,791$1,480

1.The increase from December 31, 2024 to September 30, 2025 was primarily due to advance payments on long-term supply agreements.

NOTE 4 – DIVESTITURES

Divestiture of Soil Fumigation Product Line

On May 1, 2025, the Company sold TeloneTM, a soil fumigation product line, and certain related assets to TriCal Soil Solutions, Inc. ("TriCal"), a distributor and applicator of soil fumigation products, for cash proceeds of $121 million, net of costs to sell and other transaction expenses and subject to customary post-closing adjustments. Under the sale and purchase agreement, Dow retained ownership of the related production assets, which are leased to TriCal as part of a toll manufacturing arrangement that directs the Company to manufacture and deliver certain products to TriCal. These asset leases are classified as operating leases. Dow and TriCal have also entered into a site services agreement related to certain services the Company will provide to TriCal at its site in Stade, Germany. Divested assets included property with a net book value of $5 million and goodwill of $10 million. The Company recognized a pretax gain of $103 million in the second quarter of 2025, included in "Sundry income (expense) - net" in the consolidated statements of income and related to Industrial Intermediates & Infrastructure.

Divestiture of Investment in DowAksa

On August 8, 2025, the Company sold its ownership interest in DowAksa Advanced Composites Holdings BV ("DowAksa"), a nonconsolidated affiliate, to its joint venture partner, Aksa Akrilik Kimya Sanayii A.Ş., for cash proceeds of $121 million, net of costs to sell and other transaction expenses and subject to customary post-closing adjustments. The Company's investment balance in DowAksa was $11 million and the Company recognized a pretax gain of $110 million in the third quarter of 2025, included in "Sundry income (expense) - net" in the consolidated statements of income and related to Corporate.

The Company evaluated the divestitures of its soil fumigation product line and its investment in DowAksa and determined they did not represent strategic shifts that had a major effect on the Company’s operations and financial results and did not qualify as individually significant components of the Company. As a result, the divestitures are not reported as discontinued operations.

NOTE 5 – RESTRUCTURING AND ASSET RELATED CHARGES - NET

Charges for restructuring programs and other asset related charges, which include asset impairments, are recorded in "Restructuring and asset related charges - net" in the consolidated statements of income. For additional information on the Company's 2023 Restructuring Program and other asset related charges, see Note 5 to the Consolidated Financial Statements included in the 2024 10-K.

2025 Restructuring Program

On January 27, 2025, the Dow Inc. Board of Directors ("Board") approved targeted actions to further achieve the Company's cost reduction initiatives in response to ongoing macroeconomic uncertainty, while reinforcing its long-term competitiveness across the economic cycle. The actions include a workforce reduction of approximately 1,500 roles. As a result of these actions, in the first quarter of 2025 the Company recorded pretax charges of $207 million for severance and related benefits costs, included in "Restructuring and asset related charges - net" in the consolidated statements of income, related to Corporate. These actions are expected to be substantially complete by the end of 2026.

Table of Contents

On June 30, 2025, the Board approved restructuring actions to rationalize the Company's global asset footprint, including certain actions identified as part of the Company's previously announced strategic review of its European assets and certain corporate and other assets, and to enhance the Company's competitiveness over the economic cycle. The program includes asset write-down and write-off charges, severance and related benefit costs and other exit and disposal costs. As a result of these actions, in the second quarter of 2025, the Company recorded pretax restructuring charges of $591 million, consisting of severance and related benefit costs of $154 million, asset write-downs and write-offs of $334 million and costs associated with exit and disposal activities of $103 million. In the third quarter of 2025, the Company recorded additional pretax restructuring charges of $23 million, consisting of asset write-downs and write-offs of $8 million and costs associated with exit and disposal activities of $15 million. The impact of these charges is shown as "Restructuring and asset related charges - net" in the consolidated statements of income. See Note 21 for additional information on nonrecurring fair value measurements. The following table summarizes the activities related to the 2025 Restructuring Program, including segment information:

2025 Restructuring ProgramSeverance and Related Benefit CostsAsset Write-downs and Write-offsCosts Associated with Exit and Disposal ActivitiesTotal
In millions
Corporate$207$—$—$207
Total restructuring charges$207$—$—$207
Reserve balance at Mar 31, 2025$207$—$—$207
Packaging & Specialty Plastics$—$81$77$158
Industrial Intermediates & Infrastructure—632689
Performance Materials & Coatings—147—147
Corporate15443—197
Total restructuring charges$154$334$103$591
Charges against the reserve 1—(334)(103)(437)
Cash payments(16)——(16)
Reserve balance at Jun 30, 2025$345$—$—$345
Packaging & Specialty Plastics$—$3$—$3
Industrial Intermediates & Infrastructure—156
Performance Materials & Coatings—3—3
Corporate—11011
Total restructuring charges$—$8$15$23
Charges against the reserve 1—(8)(15)(23)
Cash payments(66)——(66)
Reserve balance at Sep 30, 2025$279$—$—$279

1.Costs associated with exit and disposal activities relate to asset retirement obligations and pension benefit settlement costs.

At September 30, 2025, $141 million of the restructuring reserve balance was included in "Accrued and other current liabilities" and $138 million was included in "Other noncurrent obligations" in the consolidated balance sheets.

The Company recorded pretax restructuring charges of $821 million inception-to-date under the 2025 Restructuring Program, consisting of severance and related benefit costs of $361 million, asset write-downs and write-offs of $342 million and costs associated with exit and disposal activities of $118 million.

Restructuring implementation costs, primarily decommissioning and demolition activities related to asset actions and costs associated with the Company's restructuring actions, are expected to result in additional cash expenditures of approximately $220 million. Restructuring implementation costs totaled $5 million and $10 million for the three and nine months ended September 30, 2025, respectively.

Table of Contents

Severance and Related Benefit Costs

Severance benefits are provided to employees primarily under Dow's ongoing benefit arrangements and are accrued against the Corporate segment once management commits to a plan of termination. The 2025 Restructuring Program included charges for severance and related benefit costs of $361 million. At September 30, 2025, $82 million in severance payments had been made.

Asset Write-downs and Write-offs

The 2025 Restructuring Program included charges related to the write-down and write-off of assets totaling $342 million. Details regarding the asset write-downs and write-offs are as follows:

  • Packaging & Specialty Plastics recorded a charge to rationalize its global asset footprint by shutting down an ethylene facility in Böhlen, Germany by the end of 2027.

  • Industrial Intermediates & Infrastructure recorded a charge to primarily rationalize its global asset footprint by shutting down certain chlor-alkali and vinyl assets in Schkopau, Germany by the end of 2027.

  • Performance Materials & Coatings recorded a charge to primarily rationalize its global asset footprint by shutting down a basics siloxanes plant in Barry, United Kingdom by mid-year 2026.

  • Corporate recorded charges related to the write-down of certain Company owned and leased non-manufacturing facilities and other assets.

Costs Associated with Exit and Disposal Activities

In the first nine months of 2025, the Company accrued additional asset retirement obligations of $105 million and wrote off related deferred asset charges associated with the asset shutdowns noted above, resulting in charges of $103 million and $5 million in the second and third quarters of 2025, respectively. See Note 14 for additional information related to the Company’s asset retirement obligations.

The 2025 Restructuring Program also included a pretax charge of $10 million for net pension benefit settlement costs related to participants of a pension plan in Europe that were impacted by the restructuring program, recorded in the third quarter of 2025.

It is reasonably possible the Company will incur approximately $60 million of future charges related to costs associated with exit and disposal activities.

In addition, the Company is assessing potential environmental remediation activities associated with the asset actions noted above, which could result in additional charges and cash payments in the future. The Company intends to continue operating other assets at the sites impacted by these actions.

2023 Restructuring Program

Actions related to the restructuring program approved by the Board on January 25, 2023, were complete at the end of the second quarter of 2025. In the first quarter of 2025, the Company recorded an additional pretax restructuring charge of $5 million for asset write-downs and write-offs and an asset related credit adjustment of $4 million, included in "Restructuring and asset related charges - net" in the consolidated statements of income, related to Industrial Intermediates & Infrastructure. See Note 21 for additional information on nonrecurring fair value measurements. Restructuring implementation and efficiency costs were zero and $50 million for the three and nine months ended September 30, 2025, respectively ($55 million and $157 million for the three and nine months ended September 30, 2024, respectively).

Table of Contents

NOTE 6 – SUPPLEMENTARY INFORMATION

Dow Inc. Sundry Income (Expense) – NetThree Months EndedNine Months Ended
In millionsSep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Non-operating pension and other postretirement benefit plan net credits 1$36$61$110$183
Foreign exchange gains (losses) 212(14)23(49)
Gain on sales of other assets and investments 3527—46
Gain on divestiture of ownership interest in DowAksa 4110—110—
Gain on divestiture of soil fumigation product line 4——103—
Gain (loss) on early extinguishment of debt 5(18)—(78)5
Indemnification and other transaction related costs 6(3)1(20)2
Other - net43449769
Total sundry income (expense) – net$185$119$345$256

1.See Note 18 for additional information.

2.Foreign exchange gains for the three and nine months ended September 30, 2025 relate primarily to exposures to the Euro, partially offset by losses in exposures to the Argentine peso. Foreign exchange losses for the three months ended September 30, 2024 relate primarily to exposures in the Argentine peso, while losses in the nine months ended September 30, 2024 relate primarily to exposures in the Egyptian pound and Argentine peso.

3.The three and nine months ended September 30, 2024 include a gain of $25 million associated with a warehouse sale.

4.See Note 4 for additional information.

5.See Note 13 for additional information.

6.Primarily related to charges associated with agreements entered into with DuPont de Nemours, Inc. ("DuPont") and Corteva, Inc. ("Corteva") as part of the separation and distribution.

Sundry income (expense) - net for TDCC for the three and nine months ended September 30, 2025 and 2024 is substantially the same as that of Dow Inc. and, therefore, Sundry income (expense) - net for TDCC is not disclosed separately.

Other Investments

The Company has investments in company-owned life insurance policies, which are recorded at their cash surrender value as of each balance sheet date, as provided below:

Investments in Company-Owned Life InsuranceSep 30, 2025Dec 31, 2024
In millions
Gross cash value$515$558
Less: Existing drawdowns 1197—
Less: Accrued interest on drawdowns 25—
Investments in company-owned life insurance 3$313$558

1.Classified as "Proceeds from sales and maturities of investments" in the consolidated statements of cash flows.

2.Included in "Sundry income (expense) - net" in the consolidated statements of income.

3.Classified as "Other investments" in the consolidated balance sheets.

Supplier Finance Program

The Company facilitates a supply chain financing (“SCF”) program in the ordinary course of business in order to extend payment terms with vendors. Under the terms of this program, a vendor can voluntarily enter into an agreement with a participating financial intermediary to sell its receivables due from the Company. The vendor receives payment from the financial intermediary, and the Company pays the financial intermediary on the terms originally negotiated with the vendor, which generally range from 90 to 120 days. The vendor negotiates the terms of the agreements directly with the financial intermediary and the Company is not a party to that agreement. The financial intermediary may allow the participating vendor to utilize the Company’s creditworthiness in establishing credit spreads and associated costs, which may provide the vendor with more favorable terms than they would be able to secure on their own. The Company does not provide guarantees related to the SCF program. At September 30, 2025, outstanding obligations confirmed as valid under the SCF program were $288 million ($291 million at December 31, 2024), included in “Accounts payable – Trade” in the consolidated balance sheets.

Table of Contents

NOTE 7 – INCOME TAXES

As the financial statements for Dow Inc. and TDCC are substantially similar, including the provision (credit) for income taxes, the following income tax discussion does not include reference to TDCC's provision (credit) for income taxes or its effective tax rate.

The Company's effective tax rate fluctuates based on, among other factors, where income is earned, the level of income relative to tax attributes and the level of equity earnings, since most earnings from the Company's equity method investments are taxed at the joint venture level.

The following table provides effective tax rate information for Dow Inc. for the three and nine months ended September 30, 2025 and 2024:

Effective Tax Rate InformationThree Months EndedNine Months Ended
Amounts in millionsSep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Income (loss) before income taxes$70$324$(963)$1,381
Provision (credit) for income taxes$(54)$84$4$145
Effective tax rate(77.1)%25.9%(0.4)%10.5%

The credit for income taxes for the three months ended September 30, 2025 was impacted by the recording of a tax benefit stemming from the U.S. Tax Court's decision in Varian Medical Systems Inc. v. Commissioner of $100 million and a tax benefit of $20 million related to the sale of an additional portion of the Company's membership interests in Diamond Infrastructure Solutions, partially offset by losses attributable to jurisdictions for which no tax benefit can be recognized. The provision for income taxes for the nine months ended September 30, 2025 was also impacted by the initial sale of a portion of the Company's membership interests in Diamond Infrastructure Solutions resulting in a tax benefit of $89 million, which was offset by valuation allowances in certain foreign jurisdictions of $242 million. See Note 17 for additional information related to the Diamond Infrastructure Solutions transaction.

In the first nine months of 2024, the Company recorded a tax benefit of $194 million related to a reassessment of interest and penalties on a tax matter in a foreign jurisdiction, resulting in a reduced effective tax rate for the period.

On July 4, 2025, U.S. legislation formally titled "An Act to Provide for Reconciliation Pursuant to Title II of H. Con. Res. 14” (“the Act”) and commonly referred to as the One Big Beautiful Bill Act was signed into law. The Act, among other things, extended key provisions of the 2017 Tax Cuts and Jobs Act and introduced targeted changes to the U.S. federal income tax regime. Based on the analysis performed by the Company to date, the Act is not expected to have a material impact on the effective tax rate.

NOTE 8 – EARNINGS PER SHARE CALCULATIONS

The following tables provide earnings per share calculations for Dow Inc. for the three and nine months ended September 30, 2025 and 2024. Earnings per share of TDCC is not presented as this information is not required in financial statements of wholly owned subsidiaries.

Net Income (Loss) for Earnings Per Share CalculationsThree Months EndedNine Months Ended
In millionsSep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Net income (loss)$124$240$(967)$1,236
Net income attributable to noncontrolling interests622611367
Net income attributable to participating securities 12399
Net income (loss) attributable to common stockholders$60$211$(1,089)$1,160

1.Restricted stock units are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares.

Table of Contents

Earnings (Loss) Per Share - Basic and DilutedThree Months EndedNine Months Ended
Dollars per shareSep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Earnings (loss) per common share - basic$0.08$0.30$(1.53)$1.65
Earnings (loss) per common share - diluted$0.08$0.30$(1.53)$1.65
Share Count InformationThree Months EndedNine Months Ended
Shares in millionsSep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Weighted-average common shares outstanding - basic711.8702.3709.4703.5
Plus dilutive effect of equity compensation plans 11.41.3—1.4
Weighted-average common shares outstanding - diluted713.2703.6709.4704.9
Stock units excluded from EPS calculations 219.310.523.69.6

1.The nine months ended September 30, 2025 reflect a net loss and, as such, the basic share count was used for purposes of calculating earnings per share on a diluted basis.

2.These outstanding stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

NOTE 9 – INVENTORIES

The following table provides a breakdown of inventories:

InventoriesSep 30, 2025Dec 31, 2024
In millions
Finished goods$3,709$3,773
Work in process1,3001,323
Raw materials839822
Supplies1,1761,039
Total$7,024$6,957
Adjustment of inventories to the LIFO basis(349)(413)
Total inventories$6,675$6,544

NOTE 10 – NONCONSOLIDATED AFFILIATES

For additional information on the Company’s nonconsolidated affiliates, see Note 11 to the Consolidated Financial Statements included in the 2024 10-K.

The Company's investments in companies accounted for using the equity method ("nonconsolidated affiliates"), by classification in the consolidated balance sheets are shown in the following table:

Investments in Nonconsolidated AffiliatesSep 30, 2025Dec 31, 2024
In millions
Investment in nonconsolidated affiliates$1,255$1,266
Other noncurrent obligations(892)(568)
Net investment in nonconsolidated affiliates$363$698

At September 30, 2025, the Company had a negative investment balance in Sadara Chemical Company of $851 million included in "Other noncurrent obligations" (negative $517 million at December 31, 2024) in the consolidated balance sheets. The increased negative investment in Sadara Chemical Company at September 30, 2025 is due to equity losses generated during the first nine months of 2025 driven by the impact of challenging macroeconomic conditions.

Table of Contents

At September 30, 2025, the Company had a negative investment balance in EQUATE Petrochemical Company K.S.C.C of $41 million included in "Other noncurrent obligations" (negative $51 million at December 31, 2024) in the consolidated balance sheets. The decrease in the negative investment was driven by equity earnings, partially offset by dividends distributed to shareholders in the first nine months of 2025.

NOTE 11 – GOODWILL

The following table shows changes in the carrying amount of goodwill by reportable segment:

GoodwillPackaging & Specialty PlasticsIndustrial Intermediates & InfrastructurePerformance Materials & CoatingsTotal
In millions
Net goodwill at Dec 31, 2024$5,118$1,092$2,355$8,565
Divestiture—(10)—(10)
Foreign currency impact135117135
Net goodwill at Sep 30, 2025$5,131$1,087$2,472$8,690

Goodwill Impairment Testing

In the second quarter of 2025, the Company identified potential indicators of goodwill impairment due to announced restructuring actions and ongoing macroeconomic challenges. As a result, the Company evaluated whether the fair value of any reporting unit may be less than its carrying amount. This assessment indicated that the Consumer Solutions reporting unit, part of the Performance Materials & Coatings segment, required an interim quantitative goodwill impairment test as of June 30, 2025. The test concluded that no goodwill impairment existed, as the fair value of the Consumer Solutions reporting unit exceeded its carrying value. Fair value was estimated using a discounted cash flow model that incorporated current market conditions and the anticipated effects of the restructuring actions. Key assumptions included projected revenue growth, discount rate, tax rate, terminal value, currency exchange rates, and long-term raw material and energy price forecasts.

In the third quarter of 2025, as a result of continued macroeconomic challenges, the Company evaluated whether the fair value of any reporting unit may be less than its carrying amount. This assessment indicated that the Packaging and Specialty Plastics reporting unit, part of the Packaging & Specialty Plastics segment, required an interim quantitative goodwill impairment test as of September 30, 2025. The test concluded that no goodwill impairment existed, as the fair value of the Packaging and Specialty Plastics reporting unit exceeded its carrying value. Fair value was estimated using a discounted cash flow model that incorporated current market conditions. Key assumptions included projected revenue growth, discount rate, tax rate, terminal value, currency exchange rates, and long-term raw material and energy price forecasts.

The Company continues to monitor key factors that could impact the fair value of its reporting units, including changes in macroeconomic conditions or industry-specific trends, deterioration in financial performance, increases in market interest rates or adverse changes in regulatory or competitive environments. If these or other adverse events occur, it may be necessary to perform additional impairment testing, which could result in a future goodwill impairment charge.

NOTE 12 – TRANSFERS OF FINANCIAL ASSETS

Accounts Receivable Programs

The Company maintains accounts receivable facilities with various financial institutions, with committed and uncommitted facilities in the United States and a committed facility in Europe (collectively, "the Programs"), which are set to expire in November 2025 and are expected to be renewed in the fourth quarter. Under the terms of the Programs, the Company may sell certain eligible trade accounts receivable at any point in time, up to $900 million for the U.S. committed facility and up to €500 million for the Europe committed facility. Under the terms of the Programs, the Company continues to service the receivables from the customer, but retains no interest in the receivables, and remits payment to the financial institutions. Losses on transfers of receivables were insignificant for the three and nine months ended September 30, 2025 and 2024. The Company also provides a guarantee to the financial institutions for the creditworthiness and collection of the receivables in satisfaction of the facility. See Note 14 for additional information related to guarantees.

Table of Contents

The Company has access to accounts receivable discounting facilities that cover certain receivables generated from sales in EMEAI, Asia Pacific and Canada (collectively, "the Facilities"). Under the terms of the Facilities, the Company retains no interest in the transferred receivables once sold and receivables are transferred with limited recourse. The Company continues to service the receivables from the customer and remits payment to the Facilities. Losses on transfers of receivables were insignificant for the three and nine months ended September 30, 2025 and 2024.

The following table provides a summary of cash flows related to the Programs and the Facilities for the three and nine months ended September 30, 2025 and 2024:

Cash Flows Related to Transfers of Accounts ReceivableThree Months EndedNine Months Ended
In millionsSep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Proceeds received from new transfers$—$198$538$1,248

The following table provides the balances related to the Programs and the Facilities at September 30, 2025 and December 31, 2024:

Balances Related to Transfers of Accounts ReceivableSep 30, 2025Dec 31, 2024
In millions
Balance outstanding$6$287
Accounts receivable derecognized$—$278
Amounts recognized in the consolidated balance sheets:
Accrued and other current liabilities 1$6$9
  1. Represents amounts collected from customers and not yet remitted by the Company.

NOTE 13 – NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

Notes PayableSep 30, 2025Dec 31, 2024
In millions
Notes payable to banks and other lenders$133$135
Period-end average interest rates40.08%36.03%
Long-Term Debt2025 Average RateSep 30, 20252024 Average RateDec 31, 2024
In millions
Promissory notes and debentures:
Final maturity 20254.55%$2085.63%$333
Final maturity 20284.80%6004.80%600
Final maturity 2029 17.53%9517.58%1,368
Final maturity 20302.10%8182.10%818
Final maturity 2031 and thereafter 15.41%11,5615.37%9,192
Other facilities:
Foreign currency notes and loans, various rates and maturities 12.56%2,2442.01%2,540
InterNotes®, varying maturities through 20534.71%8914.31%661
Medium-term notes, maturity 20254.75%14.75%1
Finance lease obligations 21,079939
Unamortized debt discount and issuance costs(231)(244)
Long-term debt due within one year 3(413)(497)
Long-term debt$17,709$15,711

1.Cost includes net fair value hedge adjustment gains of $35 million at September 30, 2025 ($9 million at December 31, 2024). See Note 20 for additional information.

2.See Note 15 for additional information.

3.Presented net of current portion of unamortized debt issuance costs.

Table of Contents

Maturities of Long-Term Debt for Next Five Years at Sep 30, 2025
In millions
2025$245
2026$207
2027$782
2028$750
2029$1,061
2030$996

2025 Activity

In the first quarter of 2025, the Company completed debt neutral liability management activities. The Company issued $1 billion of senior unsecured notes. The offering included $400 million aggregate principal amount of 5.35 percent notes due 2035 and $600 million aggregate principal amount of 5.95 percent notes due 2055. The Company used the proceeds to complete cash tender offers for certain debt securities. In total, $943 million aggregate principal amount was tendered and retired. As a result, the Company recognized a pretax loss of $60 million on the early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated statements of income, related to Corporate.

In the third quarter of 2025, the Company issued $1.4 billion of senior unsecured notes. The offering included $750 million aggregate principal amount of 4.80 percent notes due 2031 and $650 million aggregate principal amount of 5.65 percent notes due 2036. Additionally, the Company redeemed $55 million aggregate principal amount of 9.40 percent notes due 2039. As a result of the redemption, the Company recognized a pretax loss of $18 million on the early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated statements of income, related to Corporate.

In the first nine months of 2025, the Company issued an aggregate principal amount of $252 million of InterNotes®. Additionally, the Company repaid $125 million of long-term debt at maturity.

Available Credit Facilities

The following table summarizes the Company's credit facilities:

Committed and Available Credit Facilities at Sep 30, 2025
In millionsCommitted CreditAvailable CreditMaturity DateInterest
Five Year Competitive Advance and Revolving Credit Facility$5,000$5,000June 2030Floating rate
Bilateral Revolving Credit Facility300300November 2025Floating rate
Bilateral Revolving Credit Facility300300February 2026Floating rate
Bilateral Revolving Credit Facility100100March 2026Floating rate
Bilateral Revolving Credit Facility375375October 2026Floating rate
Bilateral Revolving Credit Facility150150November 2026Floating rate
Bilateral Revolving Credit Facility200200November 2026Floating rate
Bilateral Revolving Credit Facility250250March 2027Floating rate
Bilateral Revolving Credit Facility100100May 2027Floating rate
Bilateral Revolving Credit Facility350350June 2027Floating rate
Bilateral Revolving Credit Facility200200September 2027Floating rate
Bilateral Revolving Credit Facility100100October 2027Floating rate
Bilateral Revolving Credit Facility100100March 2028Floating rate
Bilateral Revolving Credit Facility100100March 2028Floating rate
Bilateral Revolving Credit Facility300300May 2028Floating rate
Bilateral Revolving Credit Facility200200September 2028Floating rate
Bilateral Revolving Credit Facility175175September 2028Floating rate
Bilateral Revolving Credit Facility100100June 2030Floating rate
Total committed and available credit facilities$8,400$8,400

Table of Contents

Debt Covenants and Default Provisions

There were no material changes to the debt covenants and default provisions related to the Company's outstanding long-term debt and primary, private credit agreements in the first nine months of 2025. For additional information on the Company's debt covenants and default provisions, see Note 14 to the Consolidated Financial Statements included in the 2024 10-K.

NOTE 14 – COMMITMENTS AND CONTINGENCIES

A summary of the Company's commitments and contingencies can be found in Note 15 to the Consolidated Financial Statements included in the 2024 10-K, which is incorporated by reference herein.

Environmental Matters

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. At September 30, 2025, the Company had accrued obligations of $1,044 million for probable environmental remediation and restoration costs ($1,113 million at December 31, 2024), including $220 million for the remediation of Superfund sites ($234 million at December 31, 2024). This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to approximately two times that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the Company's results of operations, financial condition and cash flows. It is the opinion of the Company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the Company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. As new or additional information becomes available and/or certain spending trends become known, management will evaluate such information in determination of the current estimate of environmental liability.

Litigation

Asbestos-Related Matters of Union Carbide Corporation

Each quarter, Union Carbide reviews asbestos-related claims filed, settled and dismissed, as well as average settlement and resolution costs by disease category. Union Carbide also considers additional quantitative and qualitative factors such as the nature of pending claims, trial experience of Union Carbide and other asbestos defendants, current spending for defense and processing costs, significant appellate rulings and legislative developments, trends in the tort system, and their respective effects on expected future resolution costs. Union Carbide's management considers these factors in conjunction with the most recent actuarial study and determines whether a change in the estimate is warranted. Based on Union Carbide's review of 2025 activity, it was determined that no adjustment to the accrual was required at September 30, 2025.

Union Carbide’s total asbestos-related liability for pending and future claims and defense and processing costs was $726 million at September 30, 2025 ($791 million at December 31, 2024). At September 30, 2025, approximately 26 percent of the recorded claim liability related to pending claims and approximately 74 percent related to future claims.

Legacy Matters

Groundwater Matters

The Company is the subject of various complaints related to alleged groundwater contamination based on decades-old sales and applications of certain agricultural chemical products ("Groundwater Matters"). The costs associated with these Groundwater Matters were previously covered by insurance policies that have since been depleted. In the first quarter of 2023, the Company completed a study of certain Groundwater Matters related to wells deemed to be probable and estimable based on the public reporting of sampling data and historical information to develop a reasonable estimate of the cost of pending and future claims and accrued a charge based on the estimate. In the second quarter of 2025, the Company completed a reassessment study of these Groundwater Matters based on current known factors, resulting in a reduced estimate of the cost of pending and future claims. As a result, the Company recorded a pretax credit of $106 million, included in "Cost of sales" in the consolidated statements of income and related to Corporate. In the second quarter of 2025, the Company settled a separate claim related to Groundwater Matters at a water storage district, resulting in a pretax charge of $64 million, included in "Cost of sales" in the consolidated statements of income and related to Corporate.

Table of Contents

At September 30, 2025, the total liability related to settled claims and the probable and estimable settlement of all alleged Groundwater Matters was $78 million ($155 million at December 31, 2024), which was included in “Accrued and other current liabilities” and "Other noncurrent obligations" in the consolidated balance sheets.

The Company is also the subject of other groundwater contamination complaints, including claims related to 1,4-dioxane. The Company continues to defend itself in this litigation and has determined that the Company's exposure to liability, if any, is not probable or estimable at September 30, 2025.

Other Legacy Matters

On October 10, 2024, the Company executed a settlement agreement related to arbitration for historical product claims from a divested business. As a result, the Company recorded a pretax charge of $75 million in the third quarter of 2024, which was paid in the fourth quarter of 2024. Arbitration on the matter was concluded on March 11, 2025, and, as a result, the Company recorded an additional pretax charge of $98 million in the first quarter of 2025, which is included in "Cost of sales" in the consolidated statements of income, related to Corporate, and was paid in the second quarter of 2025.

Gain Contingency - Dow v. Nova Chemicals Corporation Ethylene Asset Matter

In 2019, the Court of King's Bench of Alberta, Canada ("Court") found Nova Chemicals Corporation ("Nova") liable for engaging in a deliberate and continuing course of conduct of conversion, breach of contract, gross negligence and willful misconduct in the operation of the companies’ jointly-owned ethylene asset in Joffre, Alberta, Canada. As a result of the liability finding, which is now final and non-appealable, the Court signed a judgment ordering Nova to pay $1.43 billion Canadian dollars (equivalent to approximately $1.08 billion U.S. dollars) for damages incurred through 2012. Nova made payment in October 2019. At September 30, 2025, $201 million ($201 million at December 31, 2024) was included in "Other noncurrent obligations" in the Company's consolidated balance sheets related to the disputed portion of the damages judgment.

Following an appeal, on June 10, 2025, the Court signed a separate judgment ordering Nova to pay an additional amount of $1.62 billion Canadian dollars (equivalent to approximately $1.2 billion U.S. dollars) for damages incurred through June 2018, which had not been previously quantified. The Court again found that Nova failed to operate the companies' jointly-owned ethylene asset at full capacity during this time, depriving the Company’s subsidiaries of millions of pounds of ethylene. On August 11, 2025, the Court also awarded fees of approximately $100 million U.S. dollars, bringing Nova’s current payment obligation to approximately $1.3 billion U.S. dollars. While those awards are subject to appeal, Alberta law requires Nova to satisfy the Court’s judgment in full notwithstanding its appeal in order to avoid enforcement measures during the appeal process. Nova has since requested that the Court of Appeal of Alberta stay the execution of the judgment pending its appeal. Nova’s request departs from well-established Alberta law, and would require Nova to show, among other things, that it would be irreparably harmed by making the required payment. Nova’s request for a stay has been fully briefed and argued, and a decision is expected by year-end 2025. It is the Company’s position that Nova cannot meet the legal standard necessary to receive a stay and avoid payment pending its appeal. We expect a decision on the stay from the Court of Appeal of Alberta by year-end 2025. If the Court of Appeal of Alberta grants the stay, Nova will not be required to pay the judgment to the Company while the appeal process is ongoing.

Guarantees

The following table provides a summary of the final expiration, maximum future payments and recorded liability included in the consolidated balance sheets for guarantees:

GuaranteesSep 30, 2025Dec 31, 2024
In millionsFinal ExpirationMaximum Future PaymentsRecorded LiabilityFinal ExpirationMaximum Future PaymentsRecorded Liability
Guarantees2038$1,223$1382038$1,456$155

Table of Contents

Guarantees arise during the ordinary course of business from relationships with customers, accounts receivable facilities and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Company to make payments to the beneficiary of the guarantee. The majority of the Company’s guarantees relate to debt of nonconsolidated affiliates, which have expiration dates ranging from less than one year to 13 years. The Company’s current expectation is that future payment or performance related to the non-performance of others is considered remote.

The Company maintains accounts receivable facilities with various financial institutions, with committed and uncommitted facilities in the United States and a committed facility in Europe. Under the terms of the Programs, the Company continues to service the receivables from the customers, but retains no interest in the receivables, and remits payment to the financial institutions. The Company also has access to accounts receivable discounting facilities, under which receivables are transferred with limited recourse. The Company’s maximum guaranteed liability for the accounts receivable facilities is zero at September 30, 2025 ($239 million at December 31, 2024).

TDCC has entered into guarantee agreements related to Sadara, a nonconsolidated affiliate. Sadara reached an agreement with its lenders to re-profile its outstanding project financing debt in the first quarter of 2021. In conjunction with the debt re-profiling, TDCC entered into a guarantee of up to approximately $1.3 billion of Sadara’s debt, proportionate to the Company's 35 percent ownership interest. The debt re-profiling also includes a grace period until June 2026, during which Sadara is obligated to make interest-only payments which are guaranteed by TDCC in proportion to the Company’s 35 percent ownership interest. The Company does not expect to be required to perform under the guarantees. As part of the debt re-profiling, Sadara established a $500 million revolving credit facility guaranteed by Dow, which would be used to fund Dow’s pro-rata share of any potential shortfall during the grace period.

Asset Retirement Obligations

Asset retirement obligations are recorded as incurred and reasonably estimable, including obligations for which the timing and/or method of settlement are conditional on a future event that may or may not be within the control of the Company. The retirement of assets may involve such efforts as remediation and treatment of asbestos, contractually required demolition, and other related activities, depending on the nature and location of the assets; and retirement obligations are typically realized only upon demolition of those facilities. As a result of the asset shutdowns included in the restructuring activities discussed in Note 5, the Company accrued additional asset retirement obligations of $105 million in the first nine months of 2025. At September 30, 2025, the aggregate carrying amount of the Company's asset retirement obligations was $306 million ($174 million at December 31, 2024), which was included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets.

Table of Contents

NOTE 15 – LEASES

For additional information on the Company's leases, see Note 16 to the Consolidated Financial Statements included in the 2024 10-K.

The components of lease cost for operating and finance leases for the three and nine months ended September 30, 2025 and 2024 were as follows:

Lease CostThree Months EndedNine Months Ended
In millionsSep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Operating lease cost$104$112$319$329
Finance lease cost
Amortization of right-of-use assets - finance33319786
Interest on lease liabilities - finance13113733
Total finance lease cost4642134119
Short-term lease cost7780244242
Variable lease cost304280842803
Sublease income(3)(2)(6)(7)
Total lease cost$528$512$1,533$1,486

The following table provides supplemental cash flow and other information related to leases:

Other Lease InformationNine Months Ended
In millionsSep 30, 2025Sep 30, 2024
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases$329$334
Operating cash flows for finance leases$37$33
Financing cash flows for finance leases$83$95
Right-of-use assets obtained in exchange for lease obligations:
Operating leases$262$186
Finance leases$202$183

Table of Contents

NOTE 16 – ACCUMULATED OTHER COMPREHENSIVE LOSS

The changes in each component of accumulated other comprehensive loss ("AOCL") for the three and nine months ended September 30, 2025 and 2024 were as follows:

Accumulated Other Comprehensive LossThree Months EndedNine Months Ended
In millionsSep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Unrealized Gains (Losses) on Investments
Beginning balance$(233)$(198)$(243)$(253)
Unrealized gains (losses) on investments635978139
Tax (expense) benefit(8)(15)(13)(35)
Net unrealized gains (losses) on investments554465104
(Gains) losses reclassified from AOCL to net income (loss) 13(12)3(19)
Tax expense (benefit) 2(1)2(1)4
Net (gains) losses reclassified from AOCL to net income (loss)2(10)2(15)
Other comprehensive income (loss), net of tax57346789
Ending balance$(176)$(164)$(176)$(164)
Cumulative Translation Adjustments
Beginning balance$(1,812)$(2,056)$(2,063)$(1,891)
Gains (losses) on foreign currency translation(69)19718642
Tax (expense) benefit478625
Net gains (losses) on foreign currency translation(22)20524847
(Gains) losses reclassified from AOCL to net income (loss) 3(11)(6)(30)(13)
Other comprehensive income (loss), net of tax(33)19921834
Ending balance$(1,845)$(1,857)$(1,845)$(1,857)
Pension and Other Postretirement Benefit Plans
Beginning balance$(5,679)$(5,452)$(5,720)$(5,486)
Gains (losses) arising during the period(1)2—2
Amortization of net loss and prior service credits reclassified from AOCL to net income (loss) 436218864
Tax expense (benefit) 2(7)(5)(19)(14)
Net loss and prior service credits reclassified from AOCL to net income (loss)29166950
Other comprehensive income (loss), net of tax28186952
Ending balance$(5,651)$(5,434)$(5,651)$(5,434)
Derivative Instruments
Beginning balance$(102)$(79)$(84)$(51)
Gains (losses) on derivative instruments(4)37(13)(9)
Tax (expense) benefit2(9)(4)2
Net gains (losses) on derivative instruments(2)28(17)(7)
(Gains) losses reclassified from AOCL to net income (loss) 51741413
Tax expense (benefit) 2(4)(1)(4)(3)
Net (gains) losses reclassified from AOCL to net income (loss)1331010
Other comprehensive income (loss), net of tax1131(7)3
Ending balance$(91)$(48)$(91)$(48)
Total AOCL ending balance$(7,763)$(7,503)$(7,763)$(7,503)

1.Reclassified to "Net sales" and "Sundry income (expense) - net."

2.Reclassified to "Provision (credit) for income taxes."

3.Reclassified to "Sundry income (expense) - net."

4.These AOCL components are included in the computation of net periodic benefit cost (credit) of the Company's defined benefit pension and other postretirement benefit plans. See Note 18 for additional information.

5.Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."

Table of Contents

NOTE 17 – NONCONTROLLING INTERESTS

Ownership interests in the Company's subsidiaries held by parties other than the Company are presented separately from the Company's equity in the consolidated balance sheets as "Noncontrolling interests." The amount of consolidated net income attributable to the Company and the noncontrolling interests are both presented on the face of the consolidated statements of income.

On May 1, 2025, TDCC sold 40 percent of the membership interests in Diamond Infrastructure Solutions to InfraPark Holdings, LLC ("InfraPark"), a subsidiary of a fund managed by Macquarie Asset Management, a global infrastructure and energy asset manager, in exchange for cash proceeds of approximately $2.4 billion, inclusive of customary post-closing adjustments. On August 29, 2025, as provided under the terms of the sale and purchase agreement, InfraPark exercised its option to purchase an additional 9 percent of Diamond Infrastructure Solutions' membership interests in exchange for proceeds of approximately $540 million. Diamond Infrastructure Solutions and its subsidiaries own and operate certain non-product producing energy, environmental, pipeline and other related infrastructure assets located at five of the Company's manufacturing sites on the U.S. Gulf Coast and provide infrastructure services to Dow manufacturing assets and other third-party tenants at these locations. InfraPark's ownership is accounted for as a noncontrolling interest in Diamond Infrastructure Solutions.

Cash proceeds from the sale of membership interests are included in "Proceeds from sale of noncontrolling interests" in the consolidated statements of cash flows. The transactions resulted in an increase in "Additional paid-in capital" of $339 million and $1,879 million and an increase in "Noncontrolling interests" of $194 million and $1,028 million for the three and nine months ended September 30, 2025, respectively, recorded in the consolidated balance sheets and the consolidated statements of equity.

The following table summarizes the activity for equity attributable to noncontrolling interests for the three and nine months ended September 30, 2025 and 2024:

Noncontrolling InterestsThree Months EndedNine Months Ended
In millionsSep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Balance at beginning of period$1,361$482$496$501
Net income attributable to noncontrolling interests622611367
Distributions to noncontrolling interests 1(89)(2)(137)(41)
Cumulative translation adjustments(5)24234
Sale of noncontrolling interests194—1,028—
Other———(1)
Balance at end of period$1,523$530$1,523$530
  1. Includes dividends paid to a joint venture of zero and $8 million for the three and nine months ended September 30, 2025 ($8 million for the three and nine months ended September 30, 2024) which were reclassified to "Equity in earnings (losses) of nonconsolidated affiliates" in the consolidated statements of income. The three and nine months ended September 30, 2025 also include $51 million of dividends declared but not paid, included in "Accrued and other current liabilities" in the consolidated balance sheets.

Table of Contents

NOTE 18 – PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS

A summary of the Company's pension and other postretirement benefit plans can be found in Note 19 to the Consolidated Financial Statements included in the 2024 10-K. The following table provides the components of the Company's net periodic benefit cost (credit) for all significant plans:

Net Periodic Benefit Cost (Credit) for All Significant PlansThree Months EndedNine Months Ended
In millionsSep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Defined Benefit Pension Plans
Service cost$12$14$33$42
Interest cost251252746754
Expected return on plan assets(324)(345)(965)(1,034)
Amortization of prior service credit(4)(3)(10)(10)
Amortization of net loss4234123105
Settlement cost 110—10—
Net periodic benefit credit$(13)$(48)$(63)$(143)
Other Postretirement Benefit Plans
Service cost$—$1$2$3
Interest cost11113133
Amortization of net gain(12)(10)(35)(31)
Net periodic benefit cost (credit)$(1)$2$(2)$5

1.Related to the settlement of certain plan obligations of a European plan resulting from the 2025 Restructuring Program. See Note 5 for additional information.

Except for the settlement cost component related to the 2025 Restructuring Program, which is included in "Restructuring and asset related charges - net" in the consolidated statements of income, the non-service cost components of net periodic benefit cost (credit) are included in "Sundry income (expense) - net" in the consolidated statements of income.

NOTE 19 – STOCK-BASED COMPENSATION

A summary of the Company's stock-based compensation plans can be found in Note 20 to the Consolidated Financial Statements included in the 2024 10-K.

Stock Incentive Plan

The Company grants stock-based compensation to employees and non-employee directors under the 2019 Stock Incentive Plan, as amended. Most of the Company's stock-based compensation awards are granted in the first quarter of each year.

In the first quarter of 2025, Dow Inc. granted the following stock-based compensation awards to employees:

  • 1.8 million stock options with a weighted-average exercise price of $38.34 per share and a weighted-average fair value of $8.27 per share;

  • 3.0 million restricted stock units with a weighted-average fair value of $38.34 per share; and

  • 2.1 million performance stock units with a weighted-average fair value of $38.46 per share.

There was minimal grant activity in the second and third quarters of 2025.

Employee Stock Purchase Plan

The Dow Inc. 2021 Employee Stock Purchase Plan (the "2021 ESPP") was adopted by the Board on February 11, 2021, and approved by stockholders at the Company's annual meeting on April 15, 2021. Under the 2025 annual offering of the 2021 ESPP, most employees will be eligible to purchase shares of common stock of Dow Inc. valued at up to 10 percent of their annual total base salary or wages. The number of shares purchased is determined using the amount contributed by the employee divided by the plan price. The plan price of the stock is equal to 85 percent

Table of Contents

of the fair market value (closing price) of the common stock at March 31, 2025 (beginning) or October 3, 2025 (ending) of the offering period, whichever is lower.

In the first quarter of 2025, employees subscribed to the right to purchase shares under the 2021 ESPP. In October 2025, 4.2 million shares were delivered to employees under the plan.

NOTE 20 – FINANCIAL INSTRUMENTS

A summary of the Company's financial instruments, risk management policies, derivative instruments and hedging activities can be found in Note 21 to the Consolidated Financial Statements included in the 2024 10-K.

Refer to Note 21 for a summary of the fair value of financial instruments at September 30, 2025 and December 31, 2024.

Debt Securities

The Company's investments in debt securities are primarily classified as available-for-sale. The following table provides investing results from available-for-sale securities for the nine months ended September 30, 2025 and 2024:

Investing ResultsNine Months Ended
In millionsSep 30, 2025Sep 30, 2024
Proceeds from sales of available-for-sale securities$320$1,730
Gross realized gains$6$34
Gross realized losses$(9)$(15)

The following table summarizes contractual maturities of the Company's investments in debt securities:

Contractual Maturities of Debt Securities at Sep 30, 2025CostFair Value
In millions
Within one year$113$108
One to five years1,1131,039
Six to ten years446448
After ten years549468
Total$2,221$2,063

Equity Securities

There were no material adjustments to the carrying value of the not readily determinable investments for impairment or observable price changes for the three and nine months ended September 30, 2025. There was $2 million of net unrealized losses recognized in earnings on equity securities for the three months ended September 30, 2025 ($1 million of net unrealized losses for the three months ended September 30, 2024). There was $4 million of net unrealized losses recognized in earnings on equity securities for the nine months ended September 30, 2025 ($1 million of net unrealized losses for the nine months ended September 30, 2024).

Investments in Equity SecuritiesSep 30, 2025Dec 31, 2024
In millions
Readily determinable fair value$10$14
Not readily determinable fair value$170$153

Table of Contents

Derivative Instruments

The notional amounts of the Company's derivative instruments at September 30, 2025 and December 31, 2024 were as follows:

Notional Amounts 1Sep 30, 2025Dec 31, 2024
In millions
Derivatives designated as hedging instruments:
Interest rate contracts$500$1,870
Foreign currency contracts$6,910$3,144
Derivatives not designated as hedging instruments:
Interest rate contracts$353$14
Foreign currency contracts$22,776$9,244

1.Notional amounts represent the absolute value of open derivative positions at the end of the period. Multi-leg option positions are reflected at the maximum notional position at expiration.

The notional amounts of the Company's commodity derivatives at September 30, 2025 and December 31, 2024 were as follows:

Commodity Notionals 1Sep 30, 2025Dec 31, 2024Notional Volume Unit
Derivatives designated as hedging instruments:
Hydrocarbon derivatives2.63.2million barrels of oil equivalent
Derivatives not designated as hedging instruments:
Hydrocarbon derivatives1.01.1million barrels of oil equivalent

1.Notional amounts represent the net volume of open derivative positions outstanding at the end of the period.

Maximum Maturity Dates of Derivatives Designated as Hedging InstrumentsYear
Interest rate contracts2027
Foreign currency contracts2026
Commodity contracts2028

Table of Contents

The following table provides the fair value and balance sheet classification of derivative instruments at September 30, 2025 and December 31, 2024:

Fair Value of Derivative InstrumentsSep 30, 2025Dec 31, 2024
In millionsGrossCounterparty and Cash Collateral Netting 1Net 2GrossCounterparty and Cash Collateral Netting 1Net 2
Asset derivatives
Derivatives designated as hedging instruments:
Interest rate contracts 3$1$—$1$20$(20)$—
Interest rate contracts 416(11)5———
Foreign currency contracts 382(58)2433(15)18
Foreign currency contracts 47(6)1———
Commodity contracts 3124(105)1925(14)11
Commodity contracts 474(65)946(36)10
Total$304$(245)$59$124$(85)$39
Derivatives not designated as hedging instruments:
Interest rate contracts 3$2$(2)$—$—$—$—
Foreign currency contracts 368(38)3074(16)58
Commodity contracts 320(9)1116(1)15
Commodity contracts 43(2)14(3)1
Total$93$(51)$42$94$(20)$74
Total asset derivatives$397$(296)$101$218$(105)$113
Liability derivatives
Derivatives designated as hedging instruments:
Interest rate contracts 5$—$—$—$46$(20)$26
Interest rate contracts 611(11)————
Foreign currency contracts 5131(58)7375(15)60
Foreign currency contracts 613(6)740—40
Commodity contracts 5116(106)1016(14)2
Commodity contracts 672(65)737(36)1
Total$343$(246)$97$214$(85)$129
Derivatives not designated as hedging instruments:
Interest rate contracts 5$2$(2)$—$1$—$1
Foreign currency contracts 586(38)4827(16)11
Commodity contracts 514(10)48(1)7
Commodity contracts 63(2)14(3)1
Total$105$(52)$53$40$(20)$20
Total liability derivatives$448$(298)$150$254$(105)$149

1.Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

2.Represents the net amounts included in the consolidated balance sheets.

3.Included in "Other current assets" in the consolidated balance sheets.

4.Included in "Deferred charges and other assets" in the consolidated balance sheets.

5.Included in "Accrued and other current liabilities" in the consolidated balance sheets.

6.Included in "Other noncurrent obligations" in the consolidated balance sheets.

Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets or liabilities, when applicable. The Company posted cash collateral of $11 million at September 30, 2025 ($16 million at December 31, 2024). No cash collateral was posted by counterparties with the Company at September 30, 2025 and December 31, 2024.

Table of Contents

The following table summarizes the gain (loss) of derivative instruments in the consolidated statements of income and comprehensive income for the three and nine months ended September 30, 2025 and 2024:

Effect of Derivative InstrumentsGain (loss) recognized in OCI 1Gain (loss) recognized in income 2
Three Months EndedNine Months EndedThree Months EndedNine Months Ended
In millionsSep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate contracts 3, 4$—$—$—$—$(7)$7$26$(16)
Excluded components 3, 575169————
Cash flow hedges:
Interest rate contracts 32—21(1)(2)(2)(11)
Foreign currency contracts 6(22)168(5)(5)1—6
Foreign currency contracts 717—2—————
Commodity contracts 6(4)—(15)22(12)(2)(13)(3)
Excluded components 5, 6—(2)—(8)(2)(1)(5)(5)
Excluded components 5, 7——7—3—6—
Net foreign investment hedges:
Foreign currency contracts—(45)(82)(37)————
Excluded components 5, 710641161153012
Total derivatives designated as hedging instruments$10$26$(31)$(2)$(13)$8$42$(17)
Derivatives not designated as hedging instruments:
Interest rate contracts 3$—$—$—$—$2$—$4$1
Foreign currency contracts 7————4(95)(208)(35)
Commodity contracts 6————(1)(2)(18)—
Commodity contracts 7————(1)—(1)—
Total return swap 6————26235049
Total derivatives not designated as hedging instruments$—$—$—$—$30$(74)$(173)$15
Total derivatives$10$26$(31)$(2)$17$(66)$(131)$(2)

1.OCI is defined as other comprehensive income (loss).

2.Pretax amounts.

3.Included in "Interest expense and amortization of debt discount" in the consolidated statements of income.

4.Gain (loss) recognized in income of derivatives is offset by gain (loss) recognized in income of the hedged item.

5.The excluded components are related to the time value of the derivatives designated as hedges.

6.Included in "Cost of sales" in the consolidated statements of income.

7.Included in "Sundry income (expense) - net" in the consolidated statements of income.

The following table provides the net after-tax gain (loss) expected to be reclassified from AOCL to income within the next 12 months:

Expected Reclassifications from AOCL within the next 12 monthsSep 30, 2025
In millions
Cash flow hedges:
Interest rate contracts$(3)
Commodity contracts$6
Foreign currency contracts$(14)
Net foreign investment hedges:
Excluded components$15

Table of Contents

NOTE 21 – FAIR VALUE MEASUREMENTS

A summary of the Company's recurring and nonrecurring fair value measurements can be found in Note 22 to the Consolidated Financial Statements included in the 2024 10-K.

Fair Value Measurements on a Recurring Basis

The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis:

Fair Value Measurements on a Recurring BasisSep 30, 2025Dec 31, 2024
In millionsFair Value LevelCostGainLossFair ValueCostGainLossFair Value
Assets at fair value:
Cash equivalents:
Held-to-maturity securities 1Level 2$854$—$—$854$96$—$—$96
Money market fundsLevel 2960——9601,164——1,164
Marketable securities 2Level 2558—(61)497453—(70)383
Other investments:
Debt securities: 3
Government debt 4Level 21,1208(82)1,0461,10313(123)993
Corporate bondsLevel 115——1518—(1)17
Corporate bondsLevel 288614(59)8419546(88)872
Corporate bondsLevel 3200—(39)161200—(49)151
Equity securities 3, 5Level 146—10410—14
Derivatives relating to: 6
Interest ratesLevel 2—19—19—20—20
Foreign currencyLevel 2—157—157—107—107
CommoditiesLevel 1—5—5—4—4
CommoditiesLevel 2—216—216—87—87
Total assets at fair value$4,781$3,908
Liabilities at fair value:
Long-term debt including debt due within one year 7Level 2$(18,122)$1,544$(409)$(16,987)$(16,208)$1,487$(484)$(15,205)
Guarantee liability 8Level 3(138)(155)
Derivatives relating to: 6
Interest ratesLevel 2——(13)(13)——(47)(47)
Foreign currencyLevel 2——(230)(230)——(142)(142)
CommoditiesLevel 1——(3)(3)——(1)(1)
CommoditiesLevel 2——(202)(202)——(64)(64)
Total liabilities at fair value$(17,573)$(15,614)

1.The Company's held-to-maturity securities primarily relate to treasury bills and time deposits. At September 30, 2025, $813 million is included in "Cash and cash equivalents" ($96 million at December 31, 2024) and $41 million is included in "Other current assets" (zero at December 31, 2024) in the consolidated balance sheets.

2.The Company’s investments in marketable securities are included in “Other current assets” in the consolidated balance sheets.

3.The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets.

4.U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations.

5.Equity securities with a readily determinable fair value.

6.See Note 20 for classification of derivatives in the consolidated balance sheets.

7.Cost includes fair value hedge adjustment gains of $35 million at September 30, 2025 and $9 million at December 31, 2024 on $5,538 million of debt at September 30, 2025 and $5,129 million at December 31, 2024.

8.Estimated liability for TDCC's guarantee of Sadara's debt which is included in "Other noncurrent obligations" in the consolidated balance sheets.

Cost approximates fair value for all other financial instruments.

Table of Contents

For equity securities calculated at net asset value per share (or its equivalent), the Company had $109 million in private market securities and $13 million in real estate at September 30, 2025 ($90 million in private market securities and $15 million in real estate at December 31, 2024). There are no redemption restrictions and the unfunded commitments on these investments were $72 million at September 30, 2025 and $81 million at December 31, 2024.

For assets classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The level 3 asset values represent the fair value of an investment in a corporate bond, accounted for as a debt security.

For liabilities classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the Company’s accrued liability related to the guarantee of Sadara’s debt is in proportion to the Company’s 35 percent ownership interest in Sadara. The estimated fair value of the guarantee was calculated using a "with" and "without" method. The fair value of the debt was calculated "with" the guarantee less the fair value of the debt "without" the guarantee. The "with" and "without" values were calculated using a discounted cash flow method based on contractual cash flows as well as projected prepayments made on the debt by Sadara.

Fair Value Measurements on a Nonrecurring Basis

2025 Restructuring Program

In the second quarter of 2025, the Company recorded a charge for asset write-downs and write-offs, including the write-down of certain manufacturing facilities, corporate assets, leased, non-manufacturing facilities and other miscellaneous assets. The manufacturing facilities, corporate assets and certain leased, non-manufacturing facilities and other miscellaneous assets associated with this plan were written down to zero. In addition, impairments of certain leased, non-manufacturing facilities and other miscellaneous assets, which were classified as Level 3 measurements, resulted in a write-down of right-of-use assets to a fair value of $110 million using unobservable inputs. The Company recorded impairment charges of $334 million for asset write-downs and write-offs, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics ($81 million), Industrial Intermediates & Infrastructure ($63 million), Performance Materials & Coatings ($147 million) and Corporate ($43 million). In the third quarter of 2025, the Company recorded additional impairment charges of $8 million for asset write-downs and write-offs, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics ($3 million), Industrial Intermediates & Infrastructure ($1 million), Performance Materials & Coatings ($3 million) and Corporate ($1 million).

2023 Restructuring Program

In the first quarter of 2025, the Company recorded impairment charges of $5 million for asset write-downs and write-offs, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Industrial Intermediates & Infrastructure.

NOTE 22 – VARIABLE INTEREST ENTITIES

A summary of the Company's variable interest entities ("VIEs") not discussed below can be found in Note 23 to the Consolidated Financial Statements included in the 2024 10-K.

Assets and Liabilities of Consolidated VIEs

The Company's consolidated financial statements include the assets, liabilities and results of operations of VIEs for which the Company is the primary beneficiary. The other equity holders’ interests are included in “Net income attributable to noncontrolling interests” in the consolidated statements of income and "Noncontrolling interests" in the consolidated balance sheets.

Infrastructure Entity

The Company has variable interests in Diamond Infrastructure Solutions, an entity that owns and operates infrastructure assets at certain Dow locations on the U.S Gulf Coast as discussed in Note 17. The Company's variable interests relate to its membership interest and the service contracts between Diamond Infrastructure Solutions and Dow, under which a majority of the infrastructure services are provided to Dow using pass-through and cost-plus pricing. Diamond Infrastructure Solutions became a variable interest entity effective with the noncontrolling interest transaction on May 1, 2025. Dow is deemed the primary beneficiary as a result of decision rights held as the majority member.

Table of Contents

The following table summarizes the carrying amounts of Diamond Infrastructure Solutions' assets and liabilities included in the Company’s consolidated balance sheets at September 30, 2025. Amounts presented are adjusted for intercompany eliminations.

Assets and Liabilities of Diamond Infrastructure SolutionsSep 30, 2025
In millions
Other current assets$161
Net property2,244
Other noncurrent assets216
Total assets 1$2,621
Current liabilities$397
Long-term debt172
Other noncurrent obligations340
Total liabilities 2$909

1.All assets were restricted at September 30, 2025.

2.All liabilities were nonrecourse at September 30, 2025.

Other Consolidated VIEs

In addition, the Company holds a variable interest and is the primary beneficiary of other joint ventures and entities. The following table summarizes the carrying amounts of other entities' assets and liabilities included in the Company’s consolidated balance sheets at September 30, 2025 and December 31, 2024:

Assets and Liabilities of Other Consolidated VIEsSep 30, 2025Dec 31, 2024
In millions
Cash and cash equivalents$23$22
Other current assets210250
Net property113122
Other noncurrent assets1615
Total assets 1$362$409
Current liabilities$16$24
Other noncurrent obligations1313
Total liabilities 2$29$37

1.Restricted assets totaled $187 million and $192 million at September 30, 2025 and December 31, 2024, respectively.

2.All liabilities were nonrecourse at September 30, 2025 and December 31, 2024.

Amounts presented in the consolidated balance sheets and the table above as restricted assets or nonrecourse obligations relating to consolidated VIEs at September 30, 2025 and December 31, 2024 are adjusted for intercompany eliminations.

NOTE 23 – SEGMENTS AND GEOGRAPHIC REGIONS

Sales to external customers, which are attributed to geographic regions based on customer location, were as follows:

Sales to External Customers by Geographic RegionThree Months EndedNine Months Ended
In millionsSep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
United States$3,651$3,883$11,322$11,621
EMEAI3,0903,5689,63610,624
Rest of World3,2323,4289,55010,314
Total$9,973$10,879$30,508$32,559

Table of Contents

Long-lived assets, which are attributed to geographic regions based on asset location, were as follows:

Long-Lived Assets by Geographic RegionSep 30, 2025Dec 31, 2024
In millions
United States$14,914$15,216
EMEAI2,7762,726
Rest of World4,8494,062
Total$22,539$22,004

Dow’s measure of profit/loss for segment reporting purposes is Operating EBIT as this is the manner in which the chief executive officer, chief operating officer, chief financial officer, general counsel and corporate secretary, and senior vice president of corporate development, together the "executive committee" and CODM, assesses performance and allocates resources. The CODM compares quarterly results to both the year-ago and sequential periods to assess performance and allocate resources to each segment. The Company defines Operating EBIT as earnings (i.e., "Income (loss) before income taxes") before interest, excluding the impact of significant items. Operating EBIT by segment includes all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate.

Segment Operating EBIT 1Pack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment Total
In millions
Three months ended Sep 30, 2025
Net sales$4,891$2,834$2,082$9,807
Cost of sales4,4742,7141,8519,039
SARD 2222122158502
Equity in earnings (losses) of nonconsolidated affiliates(6)(68)1(73)
Other segment income (expense) items 31023639
Segment Operating EBIT 4$199$(47)$80$232
Three months ended Sep 30, 2024
Net sales$5,516$2,962$2,214$10,692
Cost of sales4,6752,8931,8819,449
SARD 2260134169563
Equity in earnings (losses) of nonconsolidated affiliates16(17)1—
Other segment income (expense) items 32129(25)25
Segment Operating EBIT 4$618$(53)$140$705
Nine months ended Sep 30, 2025
Net sales$15,226$8,475$6,282$29,983
Cost of sales13,9678,3685,51027,845
SARD 26833654561,504
Equity in earnings (losses) of nonconsolidated affiliates40(165)2(123)
Other segment income (expense) items 3(4)63(37)22
Segment Operating EBIT 4$612$(360)$281$533
Nine months ended Sep 30, 2024
Net sales$16,461$8,921$6,609$31,991
Cost of sales13,8888,4725,69028,050
SARD 27683975231,688
Equity in earnings (losses) of nonconsolidated affiliates96(63)942
Other segment income (expense) items 32552(78)(1)
Segment Operating EBIT 4$1,926$41$327$2,294

1.Significant expense categories are presented on an operating basis, net of the impact of significant items.

2.SARD includes selling, general and administrative and research and development expenses.

3.Other segment items includes amortization of intangibles and sundry income (expense) - net.

4.Segment Operating EBIT for TDCC for the three and nine months ended September 30, 2025 and 2024 is substantially the same as that of Dow Inc. and therefore is not disclosed separately in the table above. A reconciliation of "Segment Operating EBIT" to "Income (loss) before income taxes" is provided in the following table.

Table of Contents

Reconciliation of "Segment Operating EBIT" to "Income (Loss) Before Income Taxes"Three Months EndedNine Months Ended
In millionsSep 30, 2025Sep 30, 2024Sep 30, 2025Sep 30, 2024
Segment Operating EBIT$232$705$533$2,294
+ Corporate Operating EBIT(52)(64)(144)(160)
+ Interest income4736114143
- Interest expense and amortization of debt discount221199646595
+ Significant items64(154)(820)(301)
Income (loss) before income taxes$70$324$(963)$1,381
Other Segment InformationPack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment TotalCorp. 1Total
In millions
Three months ended Sep 30, 2025
Net sales$4,891$2,834$2,082$9,807$166$9,973
Depreciation and amortization$349$158$174$681$7$688
Capital expenditures$433$72$59$564$—$564
Operating EBIT$199$(47)$80$232$(52)$180
Three months ended Sep 30, 2024
Net sales$5,516$2,962$2,214$10,692$187$10,879
Depreciation and amortization$384$155$194$733$8$741
Capital expenditures$490$165$81$736$—$736
Operating EBIT$618$(53)$140$705$(64)$641
Nine months ended Sep 30, 2025
Net sales$15,226$8,475$6,282$29,983$525$30,508
Depreciation and amortization$1,078$457$566$2,101$25$2,126
Capital expenditures$1,458$303$150$1,911$—$1,911
Operating EBIT$612$(360)$281$533$(144)$389
Nine months ended Sep 30, 2024
Net sales$16,461$8,921$6,609$31,991$568$32,559
Depreciation and amortization$1,098$443$578$2,119$24$2,143
Capital expenditures$1,434$497$242$2,173$—$2,173
Operating EBIT$1,926$41$327$2,294$(160)$2,134

1.Corporate contains the reconciliation between the totals for the operating segments and the Company's totals. Net sales for Corporate are primarily related to insurance operations. Corporate expenses are primarily related to insurance operations, salaries and wages and non-business aligned environmental and legal costs.

Segment Asset InformationPack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment TotalCorp.Total
In millions
Sep 30, 2025
Total assets$30,981$12,739$11,894$55,614$5,376$60,990
Investments in nonconsolidated affiliates 1$675$401$143$1,219$36$1,255
Dec 31, 2024
Total assets$29,034$11,928$11,170$52,132$5,180$57,312
Investments in nonconsolidated affiliates 1$711$367$146$1,224$42$1,266

1.See Note 10 for additional information regarding the Company's investments in nonconsolidated affiliates.

Table of Contents

The following tables summarize the pretax impact of significant items by segment excluded from Operating EBIT:

Significant Items by Segment
In millionsPack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Mat. & CoatingsOperating Segment TotalCorp.Total
Three months ended Sep 30, 2025
2025 Restructuring Program severance and related benefit costs and asset related charges 1$(3)$(6)$(3)$(12)$(11)$(23)
Implementation costs 2————(5)(5)
Net gain on divestitures and asset sale 3————110110
Loss on early extinguishment of debt 4————(18)(18)
Total significant items by segment$(3)$(6)$(3)$(12)$76$64
Nine months ended Sep 30, 2025
Restructuring, implementation and efficiency costs, and asset related charges - net 5$—$(1)$—$(1)$(50)$(51)
2025 Restructuring Program severance and related benefit costs and asset related charges 1(161)(95)(150)(406)(415)(821)
Implementation costs 2————(10)(10)
Net gain on divestitures and asset sale 3—103—103110213
Litigation related charges, awards and adjustments 6————4242
Loss on early extinguishment of debt 4————(78)(78)
Indemnification and other transaction related costs 7————(115)(115)
Total significant items by segment$(161)$7$(150)$(304)$(516)$(820)

1.Severance and related benefit costs and impairment charges related to the write-down of certain manufacturing facilities, corporate assets, leased non-manufacturing facilities and other miscellaneous assets associated with the Company's 2025 Restructuring Program. See Note 5 for additional information.

2.Implementation costs associated with the Company's 2025 Restructuring Program and the sale of membership interests of Diamond Infrastructure Solutions.

3.The three and nine months ended September 30, 2025 relate to a gain on the sale of the Company's ownership interest in a nonconsolidated affiliate. The nine months ended September 30, 2025 also includes a gain on the sale of the soil fumigation product line. See Note 4 for additional information.

4.The Company retired outstanding long-term debt resulting in a loss on early extinguishment. See Note 13 for additional information.

5.Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. The nine months ended September 30, 2024 also includes impairment charges related to the write-down of certain manufacturing assets, partially offset by an asset related credit adjustment. See Note 5 for additional information.

6.Includes a gain associated with the reassessment of liabilities for certain accrued Groundwater Matters, partially offset by the settlement of a separate claim related to water storage district Groundwater Matters. See Note 14 for additional information.

7.Charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation. The nine months ended September 30, 2025 also includes a charge related to an arbitration settlement agreement for historical product claims from a divested business. See Note 14 for additional information.

Significant Items by SegmentPack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment TotalCorp.Total
In millions
Three months ended Sep 30, 2024
Restructuring, implementation and efficiency costs, and asset related charges - net 1$—$—$(7)$(7)$(72)$(79)
Indemnification and other transactions related costs 2————(75)(75)
Total significant items by segment$—$—$(7)$(7)$(147)$(154)
Nine months ended Sep 30, 2024
Restructuring, implementation and efficiency costs, and asset related charges - net 1$(37)$(8)$(7)$(52)$(174)$(226)
Indemnification and other transactions related costs 2————(75)(75)
Total significant items by segment$(37)$(8)$(7)$(52)$(249)$(301)

1.Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. The nine months ended September 30, 2024 also includes impairment charges related to the write-down of certain manufacturing assets.

2.Includes a charge related to an arbitration settlement agreement for historical product claims from a divested business. See Note 14 for additional information.

Table of Contents

Previous: Cover and table of contents · Next: Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.